Tekes is the main public funding organisation for research and development in Finland. Tekes funds industrial projects as well as projects in research organisations, and especially promotes innovative, risk-intensive projects. Tekes offers partners from abroad a gateway to the key technology players in Finland
| Contact Details: |
| P.O.Box 69 |
| Helsinki |
| |
| FIN-00101 |
| Finland |
| Tel: | 358 1060 55000 |
| Fax: | 358 9 694 9196 |
| Email: | tekes@tekes.fi |
| WWW: | www.fivdic.net/

|
| |
Press Releases on Tekes:
|
 |
| Finland Biotech Delegation Visits Sundia |
20th May, 2009 |
Sundia MediTech Company |
SHANGHAI, May 20 /PRNewswire-Asia/ -- A Finland Biotech Delegation visited
Sundia MediTech Company, a leading pharmaceutical R&D outsourcing CRO service
company in Shanghai, China, in April.
|
| BioCis Pharma Receives 1.6 Million EURO New Financing to Speed the Clinical Phase I/II Programme of the Company's Dermatology Product |
9th September, 2008 |
|
TURKU, Finland, September 9 /PRNewswire/ -- BioCis Pharma Ltd announced that it has received almost 1.6
million EURO new R&D financing. The money is specifically targeted for the
clinical testing
|
| Ipsat Therapies Receives €3m From Finnish National Technology Agency
|
1st June, 2005 |
Ispat |
Ipsat Therapies Receives
€3m From Finnish National Technology Agency Tekes
Helsinki,
Finland (16 June 2005)
-- Ipsat Therapies, a Finnish
biopharmaceutical company with a
|
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 213 times since April 2007, the link to the organisation's website has been followed 41 times
Search for more companies in Helsinki
Search for more companies in
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Tekes